a special supplement of ACC Docket 3
A BETTER TOMORROW: ERIC WU OF JOHNSON & JOHNSON APAC ON THE FUTURE OF HEALTHCARE
Getting to know… Eric Wu
DO YOU HAVE ANY HOBBIES? WHAT DO
YOU DO IN YOUR SPARE TIME?
I like challenging myself by going on adventures. I’m not
particularly athletic, but my wife and I have made a point
to take advantage of our time on this earth to explore as
much of it as possible. We’ve done some fun things like
spelunking to explore unmapped caves, jungle hiking
to explore rarely seen waterfalls, and deep water diving
off of remote islands. One of my favorite “adventuring”
memories is proposing to my wife at the Hanakapi’ai
Falls after an all-day hike across the Kalalau Trail in
Kauai – my wife had no idea why I was so insistent on
getting to the falls. It was such a fun experience.
WHERE ARE YOU GOING FOR YOUR NEXT VACATION?
We’re going to Thailand to spend New Year’s Eve and
my birthday with some close friends. Good family and
friends are one of the keys to health and happiness.
IF YOU COULD HAVE DINNER WITH ANYONE
LIVING OR DEAD, WHO WOULD IT BE?
Stan Lee, the godfather of comics. When I was growing
up in Taiwan and learning English, comic books played
a very large role in keeping me engaged with learning
the English language and helping me understand some
American culture. I never expected comic books would
be as big as they are today and Stan Lee has been at the
forefront since the beginning. I’ve always admired him.
maintains that in addition to its stockholders,
the company is responsible for its customers, its employees, and for the global communities working toward advancements in
the healthcare industry. The form in which
Johnson & Johnson sets out its credo makes
it clear that ethics are not contingent upon
“It’s one of the things that drew me to the
company,” says Wu. “I couldn’t believe how
many people not only understood these val-
ues, but actively sought to advance them.”
With employees in over 60 countries,
Wu feels comforted to know that ethics are
engrained into Johnson & Johnson culture.
At any given moment, he can reach out to the
most senior member of the regulatory group
and not feel intimidated. “It’s a team mental-
ity,” Wu exclaims. “By helping one another,
we ultimately provide better services to our
customers and to those in need.”
This past year, Johnson & Johnson al-
located over nine billion dollars to research
and develop more effective and innovative
ways to help address patients’ unmet needs.
In addition to its research and development
efforts, the company has provided access to
HIV therapy to thousands of patients living
in underserved areas and donated one billion
doses of VERMOX®, a chewable gastrointes-
tinal drug, to those impacted by parasitic in-
fections in developing countries. Wu empha-
sizes that he is immensely proud of Johnson
& Johnson’s efforts.
“It’s projects like these that get me excited
about the work that we do. It brings me back
to why I wanted to work in healthcare in the
first place,” he says.
By 2030, Johnson & Johnson envisions a
world without disease, and Wu stands ready
to help in that crusade. Through the develop-
ment of pre- and post-symptom treatments,
along with more effective ways to diagnose
and intercept diseases, the company hopes to
break down barriers and identify new ways to
prevent, control, and eliminate illness. While
Wu concedes that this is a lofty proposition,
he underscores Johnson & Johnson’s commit-
ment to making it happen.
“The law department is proud to support
this vision and is ready to work tirelessly to
get us there. We’re all-in,” he exclaims.
Reminiscing about his time as a child in
Taiwan, with dreams of becoming a doctor,
Wu knows that he has used his legal expertise
to help make the world a healthier place. If he
can facilitate this objective — through even
the smallest transaction — he will continue to
feel that he’s on the right path.
“Five years down the road, I just hope that
I’ve done something in the region, or around
the world, to help patients who need it,” Wu